Rozanna Meijboom

Rozanna Meijboom

Auto-generated profile, based on publicly available information

Rozanna Meijboom

Centre for Clinical Brain Sciences, University of Edinburgh

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in NeuroImage
Verified
Journal Article
Open access
EBEsther E. Bron
Esther E. Bron
MSMarion Smits
Marion Smits
WFWiesje M. van der Flier
Wiesje M. van der Flier
HVHugo Vrenken
Hugo Vrenken
FBFrederik Barkhof
Frederik Barkhof
SKStefan Klein
Stefan Klein
Algorithms for computer-aided diagnosis of dementia based on structural MRI have demonstrated high performance in the literature, but are difficult to compare as different data sets and methodology were used for evaluation. In addition, it is unclear how the algorithms would perform on previously unseen data, and thus, how they would perform in clinical practice when there is no real opportunity to adapt the algorithm to the data at hand. To address these comparability, generalizability and clinical applicability issues, we organized a grand challenge that aimed to objectively compare algorithms based on a clinically representative multi-center data set. Using clinical practice as the starting point, the goal was to reproduce the clinical diagnosis. Therefore, we evaluated algorithms for multi-class classification of three diagnostic groups: patients with probable Alzheimer's disease, patients with mild cognitive impairment and healthy controls. The diagnosis based on clinical criteria was used as reference standard, as it was the best available reference despite its known limitations. For evaluation, a previously unseen test set was used consisting of 354 T1-weighted MRI scans with the diagnoses blinded. Fifteen research teams participated with a total of 29 algorithms. The algorithms were trained on a small training set (n=30) and optionally on data from other sources (e.g., the Alzheimer's Disease Neuroimaging Initiative, the Australian Imaging Biomarkers and Lifestyle flagship study of aging). The best performing algorithm yielded an accuracy of 63.0% and an area under the receiver-operating-characteristic curve (AUC) of 78.8%. In general, the best performances were achieved using feature extraction based on voxel-based morphometry or a combination of features that included volume, cortical thickness, shape and intensity. The challenge is open for new submissions via the web-based framework: http://caddementia.grand-challenge.org.

1 October 2016 in Brain and Cognition
Verified
Journal Article
Closed access
RGRinske A. Gotink
Rinske A. Gotink
RMRozanna Meijboom
Rozanna Meijboom
MVMeike W. Vernooij
Meike W. Vernooij
MSMarion Smits
Marion Smits
MHM.G. Myriam Hunink
M.G. Myriam Hunink

16 December 2016 in European Radiology
Verified
Journal Article
Open access
PDF file
EBEsther E. Bron
Esther E. Bron
MSMarion Smits
Marion Smits
JPJanne M. Papma
Janne M. Papma
RSRebecca M. E. Steketee
Rebecca M. E. Steketee
RMRozanna Meijboom
Rozanna Meijboom
SKStefan Klein
Stefan Klein
Objectives To investigate the added diagnostic value of arterial spin labelling (ASL) and diffusion tensor imaging (DTI) to structural MRI for computer-aided classification of Alzheimer's disease (AD), frontotemporal dementia (FTD), and controls. Methods This retrospective study used MRI data from 24 early-onset AD and 33 early-onset FTD patients and 34 controls (CN). Classification was based on voxel-wise feature maps derived from structural MRI, ASL, and DTI. Support vector machines (SVMs) were trained to classify AD versus CN (AD-CN), FTD-CN, AD-FTD, and AD-FTD-CN (multi-class). Classification performance was assessed by the area under the receiver-operating-characteristic curve (AUC) and accuracy. Using SVM significance maps, we analysed contributions of brain regions. Results Combining ASL and DTI with structural MRI resulted in higher classification performance for differential diagnosis of AD and FTD (AUC = 84%; p = 0.05) than using structural MRI by itself (AUC = 72%). The performance of ASL and DTI themselves did not improve over structural MRI. The classifications were driven by different brain regions for ASL and DTI than for structural MRI, suggesting complementary information. Conclusions ASL and DTI are promising additions to structural MRI for classification of early-onset AD, early-onset FTD, and controls, and may improve the computer-aided differential diagnosis on a single-subject level. Key points • Multiparametric MRI is promising for computer-aided diagnosis of early-onset AD and FTD. • Diagnosis is driven by different brain regions when using different MRI methods. • Combining structural MRI, ASL, and DTI may improve differential diagnosis of dementia.

31 May 2015 in European Radiology
Verified
Journal Article
Open access
PDF file
RSRebecca M. E. Steketee
Rebecca M. E. Steketee
EBEsther E. Bron
Esther E. Bron
RMRozanna Meijboom
Rozanna Meijboom
GHGavin C. Houston
Gavin C. Houston
SKStefan Klein
Stefan Klein
MSMarion Smits
Marion Smits
To investigate arterial spin labeling (ASL)-MRI for the early diagnosis of and differentiation between the two most common types of presenile dementia: Alzheimer’s disease (AD) and frontotemporal dementia (FTD), and for distinguishing age-related from pathological perfusion changes.

1 December 2020 in Experimental Gerontology
Verified
Journal Article
Closed access
JCJanie Corley
Janie Corley
SCSimon R. Cox
Simon R. Cox
ATAdele M. Taylor
Adele M. Taylor
MHMaria Del C. Valdés Hernández
Maria Del C. Valdés Hernández
SMSusana Muñoz Maniega
Susana Muñoz Maniega
IDIan Deary
Ian Deary

29 March 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAgniete Kampaite
Agniete Kampaite
RGRebecka Gustafsson
Rebecka Gustafsson
EYElizabeth N. York
Elizabeth N. York
PFPeter Foley
Peter Foley
NMNiall J. J. MacDougall
Niall J. J. MacDougall
RMRozanna Meijboom
Rozanna Meijboom
Multiple Sclerosis (MS) is an autoimmune disease affecting the central nervous system, characterised by neuroinflammation and neurodegeneration. Fatigue and depression are common, debilitating, and intertwined symptoms in people with relapsing-remitting MS (pwRRMS). An increased understanding of brain changes and mechanisms underlying fatigue and depression in RRMS could lead to more effective interventions and enhancement of quality of life. To elucidate the relationship between depression and fatigue and brain connectivity in pwRRMS we conducted a systematic review. Searched databases were PubMed, Web-of-Science and Scopus. Inclusion criteria were: studied participants with RRMS (n ≥ 20; ≥ 18 years old) and differentiated between MS subtypes; published between 2001-01-01 and 2023-01-18; used fatigue and depression assessments validated for MS; included brain structural, functional magnetic resonance imaging (fMRI) or diffusion MRI (dMRI). Sixty studies met the criteria: 18 dMRI (15 fatigue, 5 depression) and 22 fMRI (20 fatigue, 5 depression) studies. The literature was heterogeneous; half of studies reported no correlation between brain connectivity measures and fatigue or depression. Positive findings showed that abnormal cortico-limbic structural and functional connectivity was associated with depression. Fatigue was linked to connectivity measures in cortico-thalamic-basal-ganglial networks. Additionally, both depression and fatigue were related to altered cingulum structural connectivity, and functional connectivity involving thalamus, cerebellum, frontal lobe, ventral tegmental area, striatum, default mode and attention networks, and supramarginal, precentral, and postcentral gyri. Qualitative analysis suggests structural and functional connectivity changes, possibly due to axonal and/or myelin loss, in the cortico-thalamic-basal-ganglial and cortico-limbic network may underlie fatigue and depression in pwRRMS, respectively, but the overall results were inconclusive, possibly explained by heterogeneity and limited number of studies. This highlights the need for further studies including advanced MRI to detect more subtle brain changes in association with depression and fatigue. Future studies using optimised imaging protocols and validated depression and fatigue measures are required to clarify the substrates underlying these symptoms in pwRRMS.